IFM Therapeutics
0 followers
‌
At IFM Therapeutics, they work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body’s first line of immunological response, and an essential component of immune function.
Industries
Headquarters
Employees
Links
Org chart
H. Martin Seidel
Chief Executive Officer
H. Martin Seidel
Collapse
Dennis Dean
Chief Development Officer
Ed Olhava
SVP of Preclinical Development
Christopher M. Lindblom
VP, Finance
Ann Santilli
Executive Assistant Office Manager
Eicke Latz
Scientific Co-founder and consultant
Shankar Venkatraman
Executive Director
Sujen Lai, PMP
Director
